OptimizeRx Corporation (NASDAQ:OPRX) Q1 2026 Earnings Call Transcript
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx First Quarter Fiscal 26 Earnings Conference Call.
Optimizerx Corp (OPRX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | P.A.W. CAPITAL PARTNERS Peter A. Wright | 160,000 | $915,200 | +78% | 0.7% |
| 2. | P.A.W. CAPITAL PARTNERS Peter A. Wright | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.60 | 321,408 | $2,443,761.45 | 389,452 | 2025-03-14 | Filing | |
| $5.01 | 20,000 | $100,220.00 | 601,253 | 2024-12-12 | Filing | |
| $15.75 | 1,000 | $15,750.00 | 5,000 | 2022-08-26 | Filing | |
| $16.45 | 6,000 | $98,723.40 | 38,660 | 2022-08-19 | Filing | |
| $15.29 | 10,700 | $163,641.52 | 461,772 | 2022-08-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.51 | 1,388 | $18,751.88 | 126,830 | 2025-12-19 | Filing | |
| $18.75 | 1,620 | $30,375.00 | 188,916 | 2025-10-03 | Filing | |
| $17.49 | 11,120 | $194,488.80 | 44,215 | 2025-08-28 | Filing | |
| $15.19 | 4,000 | $60,750.80 | 11,114 | 2024-01-09 | Filing | |
| $44.96 | 400 | $17,984.00 | 445,672 | 2022-02-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 633,842 | $3,625,576 | 0.18% | |
| 2. | 607,925 | $3,477,331 | 0.01% | |
| 3. | 477,687 | $2,731,808 | 0% | |
| 4. | 445,382 | $2,547,585 | 0% | |
| 5. | 80,602 | $461,043 | 0% |
News See All
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx' Fourth Quarter and Fiscal 2025 Earnings Conference Call. With us today is Chief Executive Officer, Steve Silvestro.
OptimizeRx (OPRX): Clinical Network Growth Drives 37% Reach Boost Amid Analyst Upgrades
OptimizeRx Corp (NASDAQ:OPRX) is one of the best performing micro cap stocks in 2025.
9 Best Performing Micro Cap Stocks in 2025
A Bloomberg report published on January 2, 2026, argues that 2025 was an everything rally.
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx's Third Quarter Fiscal Year 2025 Earnings Conference Call. With us today is Chief Executive Officer, Steve Silvestro.
OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx's Second Quarter Fiscal 2025 Earnings Conference Call.
OptimizeRx Corporation (NASDAQ:OPRX) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx First Quarter Fiscal 2025 Earnings Conference Call.
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript
Operator: Good morning, everyone, and thank you for joining OptimizeRx's Fourth Quarter and Full Year Fiscal 2024 Earnings Conference Call. With us today is Chief Executive Officer, Steve Silvestro.
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx's Third Quarter Fiscal 2024 Earnings Call. With us today is OptimizeRx's Chief Executive Officer, William Febbo.
OptimizeRx Corporation (NASDAQ:OPRX) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, everyone, and thank you for joining OptimizeRx's Second Quarter Fiscal 2024 Earnings Call. With us today is the Chief Executive Officer of OptimizeRx, William Febbo.